Parallel Advisors, LLC Jazz Pharmaceuticals PLC Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Parallel Advisors, LLC holds 76 shares of JAZZ stock, worth $9,345. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 67 13.43%

Holding current value

$9,345

Previous $7,000 14.29%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.57 - $116.37 $905 - $1,047	9 Added 13.43%	76 $8,000
Q2 2024 Aug 08, 2024	BUY	$103.94 - $118.98 $2,910 - $3,331	28 Added 71.79%	67 $7,000
Q1 2024 May 06, 2024	SELL	$115.19 - $132.77 $5,644 - $6,505	-49 Reduced 55.68%	39 $4,000
Q4 2023 Feb 09, 2024	SELL	$114.26 - $136.0 $5,370 - $6,392	-47 Reduced 34.81%	88 $10,000
Q3 2023 May 20, 2024	BUY	$122.0 - $145.31 $11,590 - $13,804	95 Added 237.5%	135 $17,000
Q3 2023 Nov 13, 2023	BUY	$122.0 - $145.31 $11,590 - $13,804	95 Added 237.5%	135 $17,000
Q2 2023 May 20, 2024	SELL	$122.5 - $147.16 $3,552 - $4,267	-29 Reduced 42.03%	40 $4,000
Q2 2023 Aug 04, 2023	SELL	$122.5 - $147.16 $3,552 - $4,267	-29 Reduced 42.03%	40 $4,000
Q1 2023 May 20, 2024	BUY	$133.98 - $160.47 $4,019 - $4,814	30 Added 76.92%	69 $10,000
Q1 2023 Apr 25, 2023	BUY	$133.98 - $160.47 $4,957 - $5,937	37 Added 115.63%	69 $10,000
Q4 2022 Feb 03, 2023	SELL	$129.72 - $159.85 $1,686 - $2,078	-13 Reduced 28.89%	32 $5,000
Q3 2022 Nov 10, 2022	SELL	$126.59 - $161.18 $1,139 - $1,450	-9 Reduced 16.67%	45 $6,000
Q2 2022 Aug 01, 2022	SELL	$141.59 - $168.66 $1,132 - $1,349	-8 Reduced 12.9%	54 $8,000
Q1 2022 Apr 28, 2022	SELL	$129.64 - $160.7 $5,963 - $7,392	-46 Reduced 42.59%	62 $10,000
Q4 2021 Jan 20, 2022	BUY	$119.87 - $145.67 $5,873 - $7,137	49 Added 83.05%	108 $14,000
Q3 2021 Nov 02, 2021	SELL	$128.64 - $184.79 $10,162 - $14,598	-79 Reduced 57.25%	59 $8,000
Q2 2021 Aug 06, 2021	BUY	$160.2 - $186.42 $1,922 - $2,237	12 Added 9.52%	138 $25,000
Q1 2021 Apr 23, 2021	BUY	$150.19 - $173.5 $4,055 - $4,684	27 Added 27.27%	126 $21,000
Q4 2020 Feb 02, 2021	SELL	$140.71 - $165.05 $6,472 - $7,592	-46 Reduced 31.72%	99 $16,000
Q3 2020 Oct 27, 2020	SELL	$105.46 - $144.13 $4,429 - $6,053	-42 Reduced 22.46%	145 $21,000
Q2 2020 Jul 16, 2020	BUY	$95.68 - $121.88 $8,324 - $10,603	87 Added 87.0%	187 $20,000
Q1 2020 Apr 27, 2020	BUY	$87.74 - $152.74 $2,632 - $4,582	30 Added 42.86%	100 $9,000
Q4 2019 Jan 30, 2020	BUY	$117.65 - $153.73 $5,529 - $7,225	47 Added 204.35%	70 $10,000
Q4 2018 Feb 05, 2019	SELL	$115.94 - $166.74 $1,391 - $2,000	-12 Reduced 34.29%	23 $2,000
Q3 2017 Nov 15, 2017	BUY	$142.62 - $155.6 $4,991 - $5,446	35 New	35 $5,000
Q3 2017 Nov 14, 2017	SELL	$142.62 - $155.6 $4,991 - $5,446	-35 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	35	35 $5,000

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Jazz Pharmaceuticals PLC Transaction History